LIGAND PHARMACEUTICALS INCORPORATED Payment for Contingent Consideration Liability, Operating Activities
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Payment for Contingent Consideration Liability, Operating Activities of $0 for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities · last filed 2018-08-08
- 2018-06-30: Payment for Contingent Consideration Liability, Operating Activities 6 month $0.00.
- 2017-06-30: Payment for Contingent Consideration Liability, Operating Activities 6 month $5.00M.
| Period end | Payment for Contingent Consideration Liability, Operating Activities 6 month |
|---|---|
| 2018-06-30 | $0.00 10-Q · filed 2018-08-08 |
| 2017-06-30 | $5.00M 10-Q · filed 2018-08-08 |